rts logo

NLS Pharmaceutics Ltd (NLSP) Stock Could Soon Reward Patient Investors

NLS Pharmaceutics Ltd (NASDAQ: NLSP) is -71.94% lower on its value in year-to-date trading and has touched a low of $0.14 and a high of $1.60 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NLSP stock was last observed hovering at around $0.18 in the last trading session, with the day’s loss setting it -0.01%.

Currently trading at $0.17, the stock is -48.28% and -59.55% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.27 million and changing -8.06% at the moment leaves the stock -75.21% off its SMA200. NLSP registered -87.07% loss for a year compared to 6-month loss of -78.51%. The firm has a 200-day simple moving average (SMA200) of -$0.36.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a -58.61% gain in the last 1 month and extending the period to 3 months gives it a -62.83%, and is -38.66% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 44.72% over the week and 24.34% over the month.

NLS Pharmaceutics Ltd (NLSP) has around 2 employees, a market worth around $5.90M and $0.00M in sales. Distance from 52-week low is 18.21% and -89.66% from its 52-week high.

NLS Pharmaceutics Ltd quarterly earnings per share for the current quarter are estimated at $0.

NLS Pharmaceutics Ltd (NLSP) Top Institutional Holders

6 institutions hold shares in NLS Pharmaceutics Ltd (NLSP), with institutional investors hold 21.90% of the company’s shares. The shares outstanding are 32.43M, and float is at 23.19M with Short Float at 0.27%. Institutions hold 14.99% of the Float.

The top institutional shareholder in the company is BVF Inc. with over 5.75 million shares valued at $0.95 million. The investor’s holdings represent 17.72% of the NLSP Shares outstanding. As of Dec 30, 2023, the second largest holder is Wells Fargo & Company with 56549.0 shares valued at $9358.0 to account for 0.17% of the shares outstanding. The other top investors are Geode Capital Management, LLC which holds 14362.0 shares representing 0.04% and valued at over $2376.0, while Renaissance Technologies, LLC holds 0.04% of the shares totaling 12677.0 with a market value of $2098.0.

Related Posts